About the journal
Journal of Experimental & Clinical Cancer Research is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,790 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1756-9966
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,790 EUR
- Articles in DOAJ
- 3898
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://jeccr.biomedcentral.com/
Index listings
- DOAJ · 2008-05-16
- MEDLINE · 1997-01-01
- PUBMED · 2008-05-15
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,790 EUR
- Declared review time (DOAJ)
- 8 weeks
- Actual review time (measured)
- 119 days received→accepted — computed from PubMed (n=75)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
3898
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
4603
Last recorded publication year
2026
h-index
184
i10-index
3573
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2008-05-16
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 30%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Journal of experimental and clinical cancer research
- Source type
- journal
- NLM unique ID (PubMed)
- 8308647
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
Show all subjects (50)
- Circular RNAs in diseases
- Circular RNAs in diseases
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Immune cells in cancer
- Immune cells in cancer
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- RNA modifications and cancer
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Wnt/β-catenin signaling in development and cancer
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Wnt/β-catenin signaling in development and cancer
- Hippo pathway signaling and YAP/TAZ
- Hippo pathway signaling and YAP/TAZ
- Immunotherapy and Immune Responses
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Immunotherapy and Immune Responses
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer Mechanisms and Therapy
- Cancer Research and Treatments
- Cancer Mechanisms and Therapy
- Cancer Research and Treatments
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- RNA Research and Splicing
- RNA Research and Splicing
- Glioma Diagnosis and Treatment
- Ubiquitin and proteasome pathways
- Glioma Diagnosis and Treatment
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Cancer-related gene regulation
Keywords (DOAJ)
- oncology
- cancer
- human tumours
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ